drugset / Trial / NCT00055614

Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00055614

Phase 1 Completed 20 enrolled Beth Israel Deaconess Medical Center
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of topotecan in treating patients who have advanced ovarian epithelial, fallopian tube, or primary peritoneal cancer.

Timeline

Start
2002-05
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Topotecan Small molecule Oral